APA (7th ed.) Citation

Fontes, M. S., Dingemanse, J., & Sidharta, P. N. (2021). Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects. Clinical pharmacology in drug development, 10(7), 718-725. https://doi.org/10.1002/cpdd.881

Chicago Style (17th ed.) Citation

Fontes, Magda S.C., Jasper Dingemanse, and Patricia N. Sidharta. "Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects." Clinical Pharmacology in Drug Development 10, no. 7 (2021): 718-725. https://doi.org/10.1002/cpdd.881.

MLA (9th ed.) Citation

Fontes, Magda S.C., et al. "Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of Aprocitentan, a Dual Endothelin Receptor Antagonist, in Healthy Japanese and Caucasian Subjects." Clinical Pharmacology in Drug Development, vol. 10, no. 7, 2021, pp. 718-725, https://doi.org/10.1002/cpdd.881.